by palligoelme@gmail.com | Oct 31, 2025 | Clinical Trials
Conditions: Multiple Sclerosis; Multiple Sclerosis (MS) – Relapsing-remitting; Multiple Sclerosis (MS) Primary Progressive; MS (Multiple Sclerosis); MS; Multiple Sclerosis (MS) Secondary Progressive Sponsors: University of California, San Francisco; Genentech,...
by palligoelme@gmail.com | Oct 30, 2025 | Clinical Trials
Sponsors: [Redacted] Withheld Sponsors: [Redacted] Withheld
by palligoelme@gmail.com | Oct 30, 2025 | Clinical Trials
Conditions: Alzheimer Disease Interventions: Other: Disclose amyloid, tau results; Other: Follow-up Assessments Sponsors: University of Wisconsin, Madison; National Institute on Aging (NIA) Not yet recruiting Conditions: Alzheimer Disease Interventions: Other:...
by palligoelme@gmail.com | Oct 30, 2025 | Clinical Trials
Conditions: Chronic Kidney Disease; Kidney Transplant; Coronary Microvascular Dysfunction (CMD); Inflammation Sponsors: Brigham and Women’s Hospital; National Heart, Lung, and Blood Institute (NHLBI); American Heart Association (AHA) Recruiting Conditions:...
by palligoelme@gmail.com | Oct 29, 2025 | Clinical Trials
Conditions: CSWS; Developmental and/or Epileptic Encephalopathies; Electrical Status Epilepticus in Sleep Interventions: Drug: Melatonin Sponsors: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Johns Hopkins University Not yet recruiting Conditions:...
by palligoelme@gmail.com | Oct 29, 2025 | Clinical Trials
Conditions: Skin Cancer Face; Skin Cancer Scalp Interventions: Drug: lidocaine 0.45%; Drug: Normal Saline Sponsors: University of Pennsylvania Not yet recruiting Conditions: Skin Cancer Face; Skin Cancer Scalp Interventions: Drug: lidocaine 0.45%; Drug: Normal...
